IPO Details

Bidding Dates

29 Mar '23 - 03 Apr '23

Minimum Investment

₹133,200 / 1 Lots (1200 Shares )

Price Range

₹105-111

Maximum Investment

₹133,200 / 1 Lots (1200 Shares )

Retail Discount

To be announced

Issue Size

₹33.30 Cr

Investor category and sub category

Qualified Institutional Buyers   |   Non-Institutional Investors  |   Retail Individual Investors   |  

Sotac Pharmaceuticals IPO Dates

Important dates with respect to IPO allotment and listing

IPO Opening Date

Mar 29, 2023

IPO Closing Date

Apr 3, 2023

Basis of Allotment

Apr 10, 2023

Initiation of Refunds

Apr 11, 2023

Credit of Shares to Demat Account

Apr 12, 2023

IPO Listing Date

Apr 13, 2023

Sotac Pharmaceuticals IPO Subscription Details

DateQIBNIIRetailTotal

Day 1Mar 29, 2023

 0.00 0.00 0.05 0.02

Day 2Mar 31, 2023

 0.00 0.72 0.15 0.23

Day 3Apr 3, 2023

 1.00 4.04 0.91 1.60

IPO Subscription Status Live

Investor Category Subscription (Times)
Qualified Institutions Buyers 1.00
Non-Institutional Buyers 4.04
Retail Investors 0.91
Employees [.]
Others [.]
Total 1.60

About Company

Sotac Pharmaceuticals of the Sotac Group manufactures pharmaceutical products for clients on a loan license and contract manufacturing basis. As of date, they have 162 corporate clients. 

The company was incorporated in 2015 and set up a manufacturing unit in Ahmedabad, Gujarat, in 2017. The manufacturing unit has an annual installed capacity of ₹90 crore tables and ₹14 crore capsules. 

The company has two primary lines of business:

  • Pharmaceutical products - Non-beta Lactam capsules, tablets, and syrups. 
  • Therapeutic portfolio - Anti-diabetic, Antipsychotic, Vitamins, Minerals, Iron, Anti-cold, Anti-allergic, Derma products, Antacids etc. 

Cadila Pharma, J.B. Chemical, Lincoln Pharma, Viatris (Mylan), Makers (IPCA), Corona remedies, Eris Life Science etc. are a few prominent clients of Sotac pharmaceuticals. 

 

The bidding window of Sotac Pharmaceuticals IPO worth ₹33.30 Cr will open on March 29, 2023, and close on April 03, 2023. The IPO size contains 3,000,000 equity shares with a face value of ₹10. The price band for the book-building IPO is fixed at ₹105-111 per share.

Sotac Pharmaceuticals Ltd. IPO Objective 

  • Investing in subsidiary and construction/upgradation of new/existing buildings in the current premises
  • Meeting capital expenditure requirements and general corporate purposes 
  • Meet issue expenses 

Should you invest in Sotac Pharmaceuticals Ltd.?

These are the top reasons to consider investing in Sotac Pharmaceutical Ltd.

  • The company serves a wide spectrum of companies for formulation development, clinical batch production, and commercial-scale production. 
  • The brand has a presence in 14 Indian states and has started direct export to distributors in the international market under the vertical of direct selling. 
  • It markets 34 products manufactured under its brand name in the offshore market and 14 in the USA market.

Sotac Pharmaceuticals Ltd. Noteworthy highlights

  • It has permission to produce 329 products under one licence and 45 under a licence from the Food and Drug Department. 
  • It featured among the ‘Top 10 Pharma Contract Manufacturers in India’ by Indian Pharma Outlook in 2022. 

Sotac Pharmaceuticals Company Financials

Particulars 6 months ending in September 30,2022 Year ending on March 31, 2022 (₹ lakh) Year ending on March 31, 2021
Revenue from Operations 3,974.83 7,314.17 4,884.32
Profit After Tax (PAT) (consolidated) 46.55 287.86 236.54
PAT Margin 9.98% 4.61% 1,97%
EBITDA 534.44 613.52 280.12
EBITDA % 17.32% 8.36% 6.44%
Period Ended As on March 31, 2022 As on March 31, 2021 As on March 31, 2020
Current Asset 2,727.32 1,332.70 1,307.15
Current Liability 2,118.78 1,094.97 1,051.75

Know before investing

Strengths

3

  1. The company manufactures and markets products under its brand name, which includes tablets, capsules, and syrups in the domestic and international markets.

  2. The promoters have a combined experience of 59 years.

  3. It operates in a scalable business model.

Risks

3

  1. The promoter group and group of Companies are involved in certain litigations and claims.

  2. It relies on a few customers to generate revenue.

  3. It is dependent on external suppliers for raw materials.

  • How to Apply in IPO
  • How to Check IPO Allotment Status
Play Button

Login to Angel One App / Website & click on IPO

Select desired IPO & tap on "Apply"

Enter UPI ID, set quantity/price & submit

Accept mandate on the UPI app to complete the process

Play Button

Login to Angel One App / Website

Choose IPO section on Home Page

Click IPO Orders

Chose the IPO application you want to view the status for

Sotac Pharmaceuticals IPO FAQs

What is Sotac Pharmaceuticals Ltd. IPO?

Sotac Pharmaceuticals IPO opens for subscription on March 29, 2023. The company aims to raise ₹ 33.30 crore by selling 3,000,000 equity shares. It is a book building IPO with a price band for IPO shares set at rs 105-111 per equity.

When will Sotac Pharmaceuticals Ltd. IPO allotment available?

The basis of the allotment date is April 10, 2023.

What will be the Sotac Pharmaceuticals Ltd. IPO lot size?

One lot of Sotac Pharmaceuticals Ltd. IPO has 1200 shares. 

When will Sotac Pharmaceuticals Ltd. IPO open for subscription?

The IPO will open on March 29, 2023.

What minimum lot size can retail investors subscribe to?

Retail investors can apply for a minimum of one lot.